fluconazole has been researched along with Infective Endocarditis in 73 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Excerpt | Relevance | Reference |
---|---|---|
"Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 8.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
" On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 7.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
"An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 7.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 7.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 7.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
"Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 7.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
"Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 7.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
"A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 7.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
"An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 7.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
"Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 7.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
"Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery." | 4.82 | Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005) |
"The serum Fungitell assay was used to trend (1→3)-β-D-glucan in a patient with Candida endocarditis to determine treatment effectiveness with fluconazole, to provide an appropriate end date for antifungal therapy, and to survey infection suppression while off treatment." | 3.85 | (1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis. ( Brown, M; Goldfarb, I; Johnson, T; Saling, C; Slim, J; Szabela, M, 2017) |
" On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas." | 3.74 | Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008) |
" The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis." | 3.73 | Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005) |
"An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months." | 3.73 | Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005) |
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C." | 3.71 | Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001) |
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis." | 3.70 | Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999) |
"Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis." | 3.69 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996) |
"A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole." | 3.69 | The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994) |
"Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C." | 3.69 | Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996) |
"An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B." | 3.68 | Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992) |
"Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C." | 3.68 | Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993) |
"Endophthalmitis is often treated with fluconazole or voriconazole, and the echinocandins are increasingly used, instead of amphotericin B, as initial therapy for osteomyelitis and endocarditis before step-down therapy to oral azole agents." | 2.52 | Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis. ( Kauffman, CA, 2015) |
" However, successful therapy with long-term administration of oral fluconazole has been reported for five patients." | 2.39 | Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. ( Amidi, M; Keys, TF; McMahon, D; Nguyen, MH; Nguyen, ML; Yu, VL, 1996) |
"Fungal endocarditis was confirmed by culturing of the resected vegetation showing mixed growth of Candida albicans and Candida tropicalis, although three consecutive blood cultures were negative for Candida species." | 1.39 | Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. ( Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B, 2013) |
"Candida endocarditis is extremely rare in term neonates, and gall bladder involvement due to candidemia has never been reported amongst neonates and infants." | 1.38 | Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis. ( Garg, A; Goyal, VK; Jajoo, M; Kumar, V, 2012) |
"Micafungin was started, patient responded, and fungemia cleared." | 1.36 | Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. ( Afonso, L; Bhargava, A; Chopra, A; Chopra, T; Dhar, S; Kumar, S; Sobel, JD, 2010) |
"Endocarditis is uncommon in infants and is exceptionally related to Candida albicans on pulmonary banding." | 1.35 | [Candida albicans endocarditis after pulmonary artery banding]. ( Acar, P; Dulac, Y; Kreitmann, B; Mansir, T; Paranon, S; Talvard, M, 2009) |
"Endocarditis is an uncommon complication of invasive candidiasis." | 1.31 | Candida endocarditis in a premature infant. ( Mogyorósy, G; Nagy, A; Soós, G, 2000) |
"Medical treatment of fungal endocarditis on prosthetic valves can be successful in selected cases." | 1.30 | A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. ( Kozelj, M; Lejko-Zupanc, T, 1997) |
"A 57-year-old male was treated for fungal endocarditis caused by Candida parapsilosis which precipitated severe cardiac valve vegetation and insufficiency." | 1.30 | A case report of Candida parapsilosis endocarditis. ( Inoue, Y; Kawada, S; Ueda, T; Yozu, R, 1998) |
"Fungal endocarditis is considered an absolute indication for valve replacement surgery." | 1.29 | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994) |
"Aspergillus endocarditis has been considered as a fatal disease because of the difficulty of diagnosis and treatment." | 1.29 | [Two cases of Aspergillus endocarditis after cardiac surgery in childhood]. ( Kawasaki, S; Komai, Y; Naitoh, Y; Noguchi, Y; Takagaki, Y, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.37) | 18.7374 |
1990's | 24 (32.88) | 18.2507 |
2000's | 28 (38.36) | 29.6817 |
2010's | 19 (26.03) | 24.3611 |
2020's | 1 (1.37) | 2.80 |
Authors | Studies |
---|---|
Sheikh, T | 1 |
Tomcho, JC | 1 |
Awad, MT | 1 |
Zaidi, SR | 1 |
Slim, J | 1 |
Saling, C | 1 |
Szabela, M | 1 |
Brown, M | 1 |
Johnson, T | 1 |
Goldfarb, I | 1 |
Rivoisy, C | 1 |
Vena, A | 1 |
Schaeffer, L | 1 |
Charlier, C | 1 |
Fontanet, A | 2 |
Delahaye, F | 1 |
Bouza, E | 2 |
Lortholary, O | 2 |
Munoz, P | 2 |
Lefort, A | 2 |
Ha, MV | 1 |
Choy, MS | 1 |
McCoy, D | 1 |
Fernandez, N | 1 |
Suh, JS | 1 |
Siciliano, RF | 1 |
Gualandro, DM | 1 |
Sejas, ONE | 1 |
Ignoto, BG | 1 |
Caramelli, B | 1 |
Mansur, AJ | 1 |
Sampaio, RO | 1 |
Pierrotti, LC | 1 |
Barbosa, G | 1 |
Golebiovski, W | 1 |
Weksler, C | 1 |
Lamas, C | 1 |
Fortes, NRQ | 1 |
Fortes, CQ | 1 |
Tarasoutchi, F | 1 |
Strabelli, TMV | 1 |
Agnelli, C | 1 |
Guinea, J | 1 |
Valerio, M | 1 |
Escribano, P | 1 |
Hernández-Torres, A | 1 |
García-Vázquez, E | 1 |
Laso-Ortiz, A | 1 |
Herrero-Martínez, JA | 1 |
Gómez-Gómez, J | 1 |
Fesharaki, SH | 1 |
Haghani, I | 1 |
Mousavi, B | 1 |
Kargar, ML | 1 |
Boroumand, M | 1 |
Anvari, MS | 1 |
Abbasi, K | 1 |
Meis, JF | 1 |
Badali, H | 1 |
Garcia, J | 1 |
Soch, K | 1 |
Matthew, E | 1 |
Surani, S | 1 |
Horseman, MA | 1 |
Anil Kumar, V | 1 |
Francis, E | 1 |
Sreehari, S | 1 |
Raj, B | 1 |
Gardiner, BJ | 1 |
Slavin, MA | 1 |
Korman, TM | 1 |
Stuart, RL | 1 |
Rivera, NT | 1 |
Bray, N | 1 |
Wang, H | 1 |
Zelnick, K | 1 |
Osman, A | 1 |
Vicuña, R | 1 |
Costa, A | 1 |
Lahmers, S | 1 |
Barry, SL | 1 |
Stanton, J | 1 |
Stern, JA | 1 |
Toyoda, S | 1 |
Tajima, E | 1 |
Fukuda, R | 1 |
Masawa, T | 1 |
Inami, S | 1 |
Amano, H | 1 |
Arikawa, T | 1 |
Yoshida, A | 1 |
Hishinuma, A | 1 |
Inoue, T | 1 |
Bressieux-Degueldre, S | 1 |
Sekarski, N | 1 |
Di Bernardo, S | 1 |
Kauffman, CA | 1 |
Marti, J | 1 |
Talvard, M | 1 |
Paranon, S | 1 |
Dulac, Y | 1 |
Mansir, T | 1 |
Kreitmann, B | 1 |
Acar, P | 1 |
Izumi, K | 1 |
Hisata, Y | 1 |
Hazama, S | 1 |
Chopra, T | 1 |
Bhargava, A | 1 |
Kumar, S | 1 |
Chopra, A | 1 |
Dhar, S | 1 |
Afonso, L | 1 |
Sobel, JD | 1 |
Smego, RA | 1 |
Ahmad, H | 1 |
Chartier, L | 1 |
Sendid, B | 1 |
Wolff, M | 1 |
Mainardi, JL | 1 |
Podglajen, I | 1 |
Desnos-Ollivier, M | 1 |
Bretagne, S | 1 |
Jajoo, M | 1 |
Kumar, V | 1 |
Goyal, VK | 1 |
Garg, A | 1 |
Kaygusuz, I | 1 |
Mulazimoglu, L | 1 |
Cerikcioglu, N | 1 |
Toprak, A | 1 |
Oktay, A | 1 |
Korten, V | 1 |
Marchetti, O | 2 |
Moreillon, P | 2 |
Entenza, JM | 2 |
Vouillamoz, J | 1 |
Glauser, MP | 2 |
Bille, J | 2 |
Sanglard, D | 2 |
Aaron, L | 1 |
Therby, A | 1 |
Viard, JP | 1 |
Lahoulou, R | 1 |
Dupont, B | 1 |
Kaloterakis, A | 1 |
Rizos, I | 1 |
Goumas, G | 1 |
Filiotou, A | 1 |
Barbetseas, J | 1 |
Papathanasiou, S | 1 |
Toutouzas, P | 1 |
Schelenz, S | 1 |
Gransden, WR | 1 |
Yeaman, MR | 1 |
Cheng, D | 1 |
Desai, B | 1 |
Kupferwasser, LI | 1 |
Xiong, YQ | 1 |
Gank, KD | 1 |
Edwards, JE | 1 |
Bayer, AS | 4 |
Prabhu, RM | 1 |
Orenstein, R | 1 |
del Castillo, M | 1 |
Wainsztein, N | 1 |
Klein, F | 1 |
Manganello, S | 1 |
Orellana, N | 1 |
Nevado, J | 1 |
De Alarcón, A | 1 |
Hernández, A | 1 |
Westling, K | 1 |
Thalme, A | 1 |
Julander, I | 1 |
Hariya, A | 1 |
Naruse, Y | 1 |
Kobayashi, T | 1 |
Endo, M | 1 |
Ikeda, Y | 1 |
Yoshii, T | 1 |
Momomura, S | 1 |
Ishiwata, S | 1 |
Maehara, A | 1 |
Minette, MS | 1 |
Ibsen, LM | 1 |
Lye, DC | 1 |
Hughes, A | 1 |
O'Brien, D | 1 |
Athan, E | 1 |
du Plessis, FA | 1 |
Helbing, WA | 1 |
Bogers, AJ | 1 |
Salamon, SA | 1 |
Fuursted, K | 1 |
Egeblad, H | 1 |
Petersen, E | 1 |
Ott, P | 1 |
Karatza, AA | 1 |
Dimitriou, G | 1 |
Marangos, M | 1 |
Christofidou, M | 1 |
Pavlou, V | 1 |
Giannakopoulos, I | 1 |
Darzentas, A | 1 |
Mantagos, SP | 1 |
Nishida, T | 1 |
Mayumi, H | 1 |
Kawachi, Y | 1 |
Tokunaga, S | 1 |
Maruyama, Y | 1 |
Nakashima, A | 1 |
Yasui, H | 1 |
Tokunaga, K | 1 |
Zahid, MA | 1 |
Klotz, SA | 1 |
Hinthorn, DR | 1 |
Cancelas, JA | 1 |
Lopez, J | 1 |
Cabezudo, E | 1 |
Navas, E | 1 |
Garcia Laraña, J | 1 |
Jimenez Mena, M | 1 |
Diz, P | 1 |
Perez de Oteyza, J | 1 |
Villalon, L | 1 |
Sanchez-Sousa, A | 1 |
Witt, MD | 2 |
Imhoff, T | 1 |
Li, C | 1 |
Czerwiec, FS | 1 |
Bilsker, MS | 1 |
Kamerman, ML | 1 |
Bisno, AL | 1 |
Wells, CJ | 1 |
Leech, GJ | 1 |
Lever, AM | 1 |
Wansbrough-Jones, MH | 1 |
Kawasaki, S | 1 |
Naitoh, Y | 1 |
Takagaki, Y | 1 |
Komai, Y | 1 |
Noguchi, Y | 1 |
Chemlal, K | 1 |
Saint-Julien, L | 1 |
Joly, V | 2 |
Farinotti, R | 1 |
Seta, N | 1 |
Yeni, P | 1 |
Carbon, C | 2 |
Fukui, T | 1 |
Suehiro, S | 1 |
Shibata, T | 1 |
Sasaki, Y | 1 |
Minamimura, H | 1 |
Hattori, H | 1 |
Kumano, H | 1 |
Kishita, H | 1 |
Kim, E | 1 |
Ghannoum, MA | 2 |
Nguyen, MH | 1 |
Nguyen, ML | 1 |
Yu, VL | 1 |
McMahon, D | 1 |
Keys, TF | 1 |
Amidi, M | 1 |
Sanati, H | 1 |
Ramos, CF | 1 |
Lejko-Zupanc, T | 1 |
Kozelj, M | 1 |
Inoue, Y | 1 |
Yozu, R | 1 |
Ueda, T | 1 |
Kawada, S | 1 |
Roel, JE | 1 |
Gamba, A | 1 |
Curone, M | 1 |
Pescio, A | 1 |
Bruno, C | 1 |
Finquelievich, J | 1 |
Ariffin, H | 1 |
Ariffin, W | 1 |
Tharam, S | 1 |
Omar, A | 1 |
de Bruyne, J | 1 |
Lin, HP | 1 |
Louie, A | 2 |
Liu, W | 2 |
Miller, DA | 1 |
Sucke, AC | 1 |
Liu, QF | 1 |
Drusano, GL | 1 |
Mayers, M | 1 |
Miller, MH | 2 |
Roger, PM | 1 |
Boissy, C | 1 |
Gari-Toussaint, M | 1 |
Foucher, R | 1 |
Mondain, V | 1 |
Vandenbos, F | 1 |
le Fichoux, Y | 1 |
Michiels, JF | 1 |
Dellamonica, P | 1 |
Mogyorósy, G | 1 |
Soós, G | 1 |
Nagy, A | 1 |
Kaw, P | 1 |
Banerjee, P | 1 |
Chen, G | 1 |
Nurozler, F | 1 |
Argenziano, M | 1 |
Oz, MC | 1 |
Naka, Y | 1 |
Saito, Y | 1 |
Takahashi, M | 1 |
Sato, A | 1 |
Katsuki, T | 1 |
Ikeda, U | 1 |
Shimada, K | 1 |
Liang, JD | 1 |
Fang, CT | 1 |
Chen, YC | 1 |
Chang, SC | 1 |
Luh, KT | 1 |
Posteraro, B | 1 |
Valentini, P | 1 |
Delogu, A | 1 |
De, RG | 1 |
Boccacci, S | 1 |
Sanguinetti, M | 1 |
Nacci, A | 1 |
Sopo, SM | 1 |
Ranno, O | 1 |
Morace, G | 1 |
Fadda, G | 1 |
Jones, JM | 1 |
Sarsam, MA | 1 |
Clarke, MA | 1 |
Hedderwick, SA | 1 |
Hernández, JA | 1 |
Gonzalez-Moreno, M | 1 |
Llibre, JM | 1 |
Aloy, A | 1 |
Casan, CM | 1 |
Venditti, M | 1 |
De Bernardis, F | 1 |
Micozzi, A | 1 |
Pontieri, E | 1 |
Chirletti, P | 1 |
Cassone, A | 2 |
Martino, P | 2 |
Yamamoto, W | 1 |
Ino, T | 1 |
Sakurabayashi, I | 1 |
Ide, H | 1 |
Yaginuma, T | 1 |
Martinez-Lacasa, J | 1 |
Maña, J | 1 |
Niubó, R | 1 |
Rufi, G | 1 |
Saez, A | 1 |
Fernández-Nogués, F | 1 |
Roupie, E | 1 |
Darmon, JY | 1 |
Brochard, L | 1 |
Saada, M | 1 |
Rekik, N | 1 |
Brun-Buisson, C | 1 |
Meloni, G | 1 |
Isalska, BJ | 1 |
Stanbridge, TN | 1 |
9 reviews available for fluconazole and Infective Endocarditis
Article | Year |
---|---|
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Defibrillators, Implantable; Echinocandins; Echoca | 2014 |
Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Echinocandins; Echocardiography; Endocarditi | 2015 |
The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Dose-R | 2011 |
Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Echocardiography; Endocarditis; Flucona | 2003 |
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Caspofu | 2005 |
[Successful surgical treatment for fungal endocarditis involving the aortic valve: report of a case].
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Combined Modality Therapy; Endocarditis | 1996 |
Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; H | 1996 |
Successful treatment of Candida albicans endocarditis in a child with leukemia--a case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Endocar | 1999 |
64 other studies available for fluconazole and Infective Endocarditis
Article | Year |
---|---|
Topics: Administration, Intravenous; Aftercare; Aged, 80 and over; Antifungal Agents; Aortic Valve; Candida | 2020 |
(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
Topics: Aged; Antifungal Agents; beta-Glucans; Biomarkers; Candida glabrata; Candidiasis; Drug Monitoring; E | 2017 |
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Management; Endocarditis; Fem | 2018 |
Candida catenulata Candidaemia and Possible Endocarditis in a Cirrhotic Patient Successfully De-escalated to Oral Fluconazole.
Topics: Abdominal Pain; Administration, Oral; Adult; Antifungal Agents; Candida; Candidemia; Endocarditis; F | 2018 |
Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Echinocandins; Endocarditis; Female; Fluconazole; | 2018 |
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echino | 2019 |
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfec | 2013 |
Endocarditis caused by Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; H | 2013 |
Tricuspid valve mycetoma in an infant successfully treated by excision and complex tricuspid valve repair followed by fluconazole therapy.
Topics: Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Infant; Male; Mycetoma; | 2014 |
Hampered by historical paradigms--echinocandins and the treatment of Candida endocarditis.
Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Endocarditis; Fluconazole; Humans; Male; M | 2014 |
Fungal pericarditis and endocarditis secondary to porcupine quill migration in a dog.
Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Endocarditis; Fluconazole; Foreign Bodies; Male; Myc | 2014 |
Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; Candida; Candidiasis; Endocarditis; Fluconazo | 2015 |
Fungal endocarditis after hybrid periventricular closure of muscular ventricular septal defect by Amplatzer occluder in a child.
Topics: Administration, Oral; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Endocarditis; Fluco | 2015 |
Candida parapsilosis endocarditis in aged patient.
Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; | 2009 |
[Candida albicans endocarditis after pulmonary artery banding].
Topics: Administration, Oral; Aneurysm, False; Aneurysm, Infected; Antifungal Agents; Candidiasis; Caspofung | 2009 |
A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aortic Valve; Combined Modality Therapy; Echocardiography; | 2009 |
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Antifungal Agents; Candidiasis; Cardiomyopathy, Hypertrophic; Echinocandins; Endocarditis; Fem | 2010 |
Diagnosis, management and outcome of Candida endocarditis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Anti | 2012 |
Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Endocarditis; Fluconazole; Gallb | 2012 |
An unusual native tricuspid valve endocarditis caused by Candida colliculosa.
Topics: Aged; Amphotericin B; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Male; Tricuspid Valve | 2003 |
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Tra | 2003 |
Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; E | 2003 |
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi | 2003 |
Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Blood Proteins; Candida albicans; Candidiasis; Colony Count, Microbial; | 2004 |
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Caspofungin; | 2004 |
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echi | 2004 |
Caspofungin: a new therapeutic option for fungal endocarditis.
Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Endocarditis; Fluconazole; Humans | 2005 |
Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Humans; Mid | 2005 |
[Fungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case].
Topics: Acute Disease; Antifungal Agents; Aortic Diseases; Arterial Occlusive Diseases; Candidiasis; Combine | 2005 |
Survival of candida sepsis in extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb | 2005 |
Excision of the tricuspid valve in a baby with Candida endocarditis.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Failure; Humans; Infant; Ni | 2007 |
Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.
Topics: Adult; Candida albicans; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Heart | 2007 |
Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endocarditis; Female; Fluconazole | 2008 |
The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
Topics: Aged; Aortic Valve Insufficiency; Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Hu | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc | 1994 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Heart; Injections, | 1993 |
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesi | 1993 |
Treatment of native valve Candida endocarditis with fluconazole.
Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Valve Di | 1995 |
[Two cases of Aspergillus endocarditis after cardiac surgery in childhood].
Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Endocarditis; Female; Fluconazole; Humans; Male; | 1996 |
Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Endocarditis; Fluc | 1996 |
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Administration Schedule; Endocarditis; | 1996 |
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; D | 1997 |
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1997 |
A case report of Candida parapsilosis endocarditis.
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Candidiasis; Catheterization, Central Venous | 1998 |
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost | 1998 |
Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
Topics: Amphotericin B; Animals; Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Candida albica | 1998 |
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis; | 1999 |
Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis; Endocarditis; Fa | 2000 |
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cyclosporine; Disease Models, Animal; Dru | 2000 |
Candida endocarditis in a premature infant.
Topics: Candida albicans; Candidiasis; Endocarditis; Fatal Outcome; Fluconazole; Humans; Infant, Newborn; In | 2000 |
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Flucon | 2001 |
Fungal left ventricular assist device endocarditis.
Topics: Amphotericin B; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endocarditis; | 2001 |
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiogra | 2001 |
Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis.
Topics: Amphotericin B; Candida albicans; Candidiasis; Endocarditis; Epidural Abscess; Female; Fluconazole; | 2001 |
Candida albicans endocarditis diagnosed by PCR-based molecular assay in a critically ill pediatric patient.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Child, Preschool; Critical Illness; Down Syndrome; | 2002 |
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocardi | 2002 |
Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; HIV Infections; Humans | 1992 |
Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis.
Topics: Adult; Antibodies, Fungal; Antigens, Fungal; Candida albicans; Candidiasis; DNA Fingerprinting; DNA, | 1992 |
[A case of Candida albicans endocarditis with impaired lung function].
Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lung Diseases; Male; Middle | 1992 |
Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.
Topics: Amphotericin B; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mycose | 1991 |
Fluconazole therapy of candidal native valve endocarditis.
Topics: Candidiasis; Endocarditis; Fluconazole; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1991 |
Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor.
Topics: Adult; Candidiasis; Colony-Stimulating Factors; Drug Therapy, Combination; Endocarditis; Fluconazole | 1990 |
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve; | 1988 |